Ovid Therapeutics (OVID) Interest Coverage Ratio Growth (3y) (2019 - 2026)
Ovid Therapeutics (OVID) Interest Coverage Ratio Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 28.11% |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | 29.47% |
| 10 | Ovid Therapeutics | 120.41 Mn | -35.11 Mn | - | -6.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.47% |
| Sep 30, 2025 | 49.47% |
| Jun 30, 2025 | 30.71% |
| Mar 31, 2025 | 1.28% |
| Dec 31, 2024 | 77.85% |
| Sep 30, 2024 | -13.72% |
| Jun 30, 2024 | 26.48% |
| Mar 31, 2024 | -29.37% |
| Dec 31, 2023 | 52.76% |
| Sep 30, 2023 | 29.81% |
| Jun 30, 2023 | -23.98% |
| Mar 31, 2023 | 13.84% |
| Dec 31, 2022 | -270.62% |
| Sep 30, 2022 | 7.36% |
| Jun 30, 2022 | 59.53% |
| Dec 31, 2021 | 49.48% |
| Sep 30, 2021 | 51.79% |
| Jun 30, 2021 | 31.70% |
| Mar 31, 2021 | 60.37% |
| Dec 31, 2020 | -190.39% |